1. Campbell MK, Elbourne DR, Altman DG for the CONSORT Group. CONSORT statement: extension to cluster randomised trials. British Medical Journal2004; 328: 702–708.
2.
2. Eldridge SM, Ashby D, Feder GS. Informed patient consent to participation in cluster randomized trials: an empirical exploration of trials in primary care. Clinical Trials2005; 2: 91–98.
3.
3. Turner RM, Thompson SG, Spiegelhalter DJ. Prior distributions for the intracluster correlation coefficient, based on multiple previous estimates, and their application in cluster randomised trials. Clinical Trials2005; 2: 108–118.
4.
4. Farrin A, Underwood M. Differential recruitment in a cluster-randomised trial in primary care–the experience of the UK Back pain, Exercise, Active management and Manipulation (UK BEAM) feasibility study. Clinical Trials2005; 2: 119–124.
5.
5. Roberts C, Roberts SA. The analysis of clinical trials with clustering effects due to treatment. Clinical Trials2005; 2: 152–162.
6.
6. Lee KJ, Thompson SG. The use of random effects models to allow for clustering in individually randomised trials. Clinical Trials2005; 2: 186–193.
7.
7. Kerry SM, Cappuccio FP, Emmett L, Plange-Rhule J, Eastwood JB. Reducing selection bias in a cluster randomised trial in 12 West African villages. Clinical Trials2005; 2: 125–129.
8.
8. Raab GM, Butcher I. Parametric and non-parametric analyses for balanced group-randomised trials. Clinical Trials2005; 2: 130–140.
9.
9. White IR, Thomas J. Standardised mean differences in individually-randomised and cluster-randomised trials, with applications to meta-analysis. Clinical Trials2005; 2: 141–151.
10.
10. Campbell MK, Fayers PM, Grimshaw JM. Determinants of the intracluster correlation coefficient in cluster randomized trials. Clinical Trials2005; 2: 99–107.
